Bum Jobs Number Boo...
Health Care: Drugs
AVI BioPharma Inc. (AVII: NASDAQ)
$0.62 -0.03 | -5.22%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.62 |
| 52 Week High | 1.70 |
| 52 Week Low | 0.43 |
| Avg. Daily Vol. (Mil) | 1.42 |
| Beta (3 year) | 0.95 |
| Share Related Items | |
| Mkt Cap (Mil) | 83.60 |
| Shares Out (Mil) | 135.74 |
| Float (Mil) | 134.62 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.20 |
| Current Ratio | 1.30 |
| LT Debt/ Equity | 0.12 |
| Total Debt / Equity | 0.13 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.90 |
| Price/Book | 5.96 |
| Price/Cash Flow | -4.10 |
| Per Share Data | |
| Earnings | -0.16 |
| Sales | 0.32 |
| Book Value | 0.10 |
| Cash Flow | -0.15 |
| Business Summary | |
|---|---|
| AVI BioPharma, Inc. is focused on the discovery and development of novel RNA-based therapeutics for rare and infectious diseases, as well as other select disease targets. | |
| General Information | |
| 3450 Monte Villa Parkway
Suite 101 Bothell, WA 98021 |
|
| www.avibio.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 98 | |
| CEO: Mr. Christopher Garabedi | |
| Short Interest | |
| Current Month (Mil) | 8.22 |
| Previous Month (Mil) | 7.02 |
| Short Interest Ratio (Days) | 8.90 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -46.90 |
| Return on Investments | -138.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | -49.60 |
| Profit Margin | -49.80 |
Portfolios with AVII
- Portfolio NameUser Type
- ContributorUnder-$10 Setting Up To Tra...
- UserSMITTY
- UserJKE 1
- Useraranea
- ContributorBreakout Stocks Of The Week...
- ContributorBarron's Summary 6-12-2010
- Userwilliam d stratton Portfolio 1
- UserThe Gamble Man
- ContributorBarron's Activist Stocks 3-...
- Usermchish Portfolio 1
Latest AVII Headlines from TheStreet
- Biotech Stock Mailbag: AVI, Aveo, Spectrum 04.27.12 | 06:04 am
- Avon Slams the Door on Coty's Offer
04.02.12 | 11:04 am - 'Genetic Fix' From AVI Biopharma Builds Key Muscle Function Protein 04.02.12 | 09:04 am
- 5 Stocks Under $10 Poised for Big Upside 02.03.12 | 02:02 pm
- AVI BioPharma Stock Gaps Down On Today's Open (AVII) 10.14.11 | 09:10 am
- Identive Technologies, AMR:Small-Cap Winners 04.12.11 | 02:04 pm
- AVI BioPharma Stock Gaps Down On Today's Open (AVII) 04.01.11 | 09:04 am
- BIO CEO Conference Live Blog: Day 2 02.15.11 | 03:02 pm
- Biotech Stock Mailbag - Titan Pharma 10.22.10 | 08:10 am
- Rodman Rambles: Promising Biotechs 09.15.10 | 10:09 am
Press Releases for AVII
Partner Headlines for AVII
- AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance - Benzinga 06.01.12 | 04:06 pm
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 05.04.12 | 09:05 am
- Zacks #1 Rank Additions for Wednesday - Tale of the Tape - Zacks 05.02.12 | 09:05 am
- Barron's Recap (3/31/12): What a Power Shift in Congress Would Mean for Investors - Benzinga 04.01.12 | 09:04 am
- Wedbush Lowers PT on AVI Biopharma to $2.50 - Benzinga 11.18.11 | 09:11 am
- 19 Small Cap Stocks Boosted By Institutional Buying - Seeking Alpha 10.11.11 | 08:10 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 08.08.11 | 09:08 am
- Biotech and Drug Stocks Are Hot - Seeking Alpha 01.09.11 | 06:01 am
- UPDATE 1-AVI BioPharma names board member as new CEO - Reuters 12.13.10 | 07:12 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 10.12.10 | 09:10 am
